|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▼
|
Status ▲
|
|
PRALSETINIB |
L01EX23 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
RIPRETINIB |
L01EX19 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
VOSORITIDE |
M05BX07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005475 |
26-08-2021 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/004662 |
18-08-2021 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
ELIVALDOGENE AUTOTEMCEL |
N07XX00 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/003690 |
16-07-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
EVINACUMAB |
C10AX17 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
TRALOKINUMAB |
D11AH07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005255 |
17-06-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
SOMAPACITAN |
H01AC07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005030 |
31-03-2021 |
VALID
|
|
CENOBAMATE |
N03AX25 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005377 |
26-03-2021 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005410 |
26-03-2021 |
VALID
|
|
REMIMAZOLAM |
N05CD14 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005246 |
26-03-2021 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
TUCATINIB |
L01EH03 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005263 |
11-02-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005322 |
08-02-2021 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005321 |
17-12-2020 |
VALID
|
|
CABOTEGRAVIR |
J05AJ04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004976 |
17-12-2020 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
LUMASIRAN |
A16AX18 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005169 |
18-11-2020 |
VALID
|
|
ACALABRUTINIB |
L01EL02 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005299 |
05-11-2020 |
VALID
|
|
CRIZANLIZUMAB |
B06AX01 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004874 |
28-10-2020 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
BUPIVACAINE AND MELOXICAM |
N01BB59 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005205 |
24-09-2020 |
VALID
|
|
FILGOTINIB |
L04AF04 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
IMLIFIDASE |
L04AA41 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004849 |
25-08-2020 |
VALID
|
|
IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR |
R07AX32 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005269 |
21-08-2020 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
PRETOMANID |
J04AK08 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005167 |
31-07-2020 |
VALID
|
|
LEFAMULIN |
J01XX12 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005048 |
27-07-2020 |
VALID
|